1,25-dihydroxyvitamin D
Selected indexed studies
- 1,25-dihydroxyvitamin D mediated hypercalcemia in seminoma. (Am J Med Sci, 2025) [PMID:39179106]
- 1,25-dihydroxyvitamin D-mediated hypercalcemia associated with solid organ malignancy: a systematic review. (Minerva Endocrinol (Torino), 2025) [PMID:34581546]
- Vitamin D metabolism, mechanism of action, and clinical applications. (Chem Biol, 2014) [PMID:24529992]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- 1,25-dihydroxyvitamin D mediated hypercalcemia in seminoma. (2025) pubmed
- 1,25-dihydroxyvitamin D-mediated hypercalcemia associated with solid organ malignancy: a systematic review. (2025) pubmed
- Vitamin D metabolism, mechanism of action, and clinical applications. (2014) pubmed
- Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review. (2023) pubmed
- Epigenetic regulation during 1,25-dihydroxyvitamin D(3)-dependent gene transcription. (2023) pubmed
- 1,25-Dihydroxyvitamin D(3) Inhibits Lipopolysaccharide-Induced Interleukin-6 Production by C2C12 Myotubes. (2020) pubmed
- Hereditary 1,25-Dihydroxyvitamin D-resistant rickets. (2003) pubmed
- Impact of 1,25-dihydroxyvitamin D(3) PLGA-nanoparticles/chitosan hydrogel on osteoimmunomodulation. (2023) pubmed
- 1,25-Dihydroxyvitamin D Enhances the Regenerative Function of Lgr5(+) Intestinal Stem Cells In Vitro and In Vivo. (2024) pubmed
- Vitamin D action: lessons learned from hereditary 1,25-dihydroxyvitamin-D-resistant rickets patients. (2012) pubmed